| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K07442505 |
| PharmacoGx | BRD-K07442505 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATE1 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | RAB42 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.04 |
| mRNA | VPS39 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | OR52B2 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | EXOC3L1 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | SPSB3 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | WASF1 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.04 |
| mRNA | LRRC45 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | UBB | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | GAL3ST1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.04 |
